Evidence map›Paper›PMID 31318899›Full record

ArticlePloS one2019

Increased expression of blood muscarinic receptors in patients with reflex syncope.

Maxime Beutelstetter, Angelo Livolsi, Hugues Greney, Pauline Helms, Catherine Schmidt-Mutter, Charlie De Melo, Gerald Roul, Florian Zores, Alexandre Bolle, Nassim Dali-Youcef and 9 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Malignant vasovagal syncope in children.World journal of pediatrics : WJP · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Maxime BeutelstetterClinical Investigation Center, INSERM 1434, University Hospital of Strasbourg, Strasbourg, France.
Angelo LivolsiUnit of Cardiopediatrics, University Hospital of Strasbourg, Strasbourg, France.
Hugues GreneyLaboratory of Neurobiology and Cardiovascular Pharmacology, Federation of Translational Medicine, University of Strasbourg, Faculty of Medicine, Strasbourg, France.
Pauline HelmsUnit of Cardiopediatrics, University Hospital of Strasbourg, Strasbourg, France.
Catherine Schmidt-MutterClinical Investigation Center, INSERM 1434, University Hospital of Strasbourg, Strasbourg, France.
Charlie De MeloUnit of Neonatal Intensive Care, University Hospital of Strasbourg, Strasbourg, France.ORCID 0000-0002-2529-7061
Gerald RoulUnit of Cardiology, University Hospital of Strasbourg, Strasbourg, France.
Florian ZoresSpecialized Medical Group-The Premium, Strasbourg, France.
Alexandre BolleClinical Investigation Center, INSERM 1434, University Hospital of Strasbourg, Strasbourg, France.
Nassim Dali-YoucefLaboratory of Biochemistry and Molecular Biology, University Hospital of Strasbourg, Strasbourg, France.
Magali BeaugeyLaboratory of Neurobiology and Cardiovascular Pharmacology, Federation of Translational Medicine, University of Strasbourg, Faculty of Medicine, Strasbourg, France.
Alban SimonClinical Investigation Center, INSERM 1434, University Hospital of Strasbourg, Strasbourg, France.
Nathalie NiederhofferLaboratory of Neurobiology and Cardiovascular Pharmacology, Federation of Translational Medicine, University of Strasbourg, Faculty of Medicine, Strasbourg, France.ORCID 0000-0003-4075-3675
Jacques RegnardPhysiology-Functional Explorations, Regional University Hospital of Besançon, Besançon, France.
Malika BouhaddiPhysiology-Functional Explorations, Regional University Hospital of Besançon, Besançon, France.
Chris AdamopoulosUnit of Cardiopediatrics, University Hospital of Strasbourg, Strasbourg, France.
Mickael SchaefferDepartment of Public Health, methods in clinical research, University of Strasbourg, Strasbourg, France.
Erik SauleauDepartment of Public Health, methods in clinical research, University of Strasbourg, Strasbourg, France.
Pascal BousquetClinical Investigation Center, INSERM 1434, University Hospital of Strasbourg, Strasbourg, France.ORCID 0000-0003-4391-0365
Université de Strasbourg · FRInserm · FRCentre Hospitalier Universitaire de Besançon · FRInstitut de génétique et de biologie moléculaire et cellulaire · FRPremier Research Group · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsPathophysiology of reflex syncope is not fully understood but a vagal overactivity might be involved in this syncope. Previously, overexpression of muscarinic M2 receptors and acetylcholinesterase was found in particular in the heart and in lymphocytes of rabbits with vagal overactivity as well as in hearts of Sudden Infant Death Syndromes. The aim of this present study was to look at M2 receptor expression in blood of patients with reflex syncope. The second objective was to measure acetylcholinesterase expression in these patients. METHODS AND

results136 subjects were enrolled. This monocenter study pooled 45 adults exhibiting recurrent reflex syncope compared with 32 healthy adult volunteers (18-50 years) and 38 children exhibiting reflex syncope requiring hospitalization compared with 21 controls (1-17 years). One blood sample was taken from each subject and blood mRNA expression of M2 receptors was assessed by qRT-PCR. Taking into account the non-symmetric distributions of values in both groups, statistical interferences were assessed using bayesian techniques. A M2 receptor overexpression was observed in adult and pediatric patients compared to controls. The medians [q1;q3] were 0.9 [0.3;1.9] in patients versus 0.2 [0.1;1.0] in controls; the probability that M2 receptor expression was higher in patients than in controls (Pr[patients>controls]) was estimated at 0.99. Acetylcholinesterase expression was also increased 0.7 [0.4;1.6] in patients versus 0.4 [0.2;1.1] in controls; the probability that acetylcholinesterase expression was higher in patients than in controls (Pr[patients>controls]) was estimated at 0.97. Both in adults and children, the expression ratio of M2 receptors over acetylcholinesterase was greater in the patient group compared with the control group.

conclusionM2 receptor overexpression has been detected in the blood of both, adults and children, exhibiting reflex syncope. As in our experimental model, i.e. rabbits with vagal overactivity, acetylcholinesterase overexpression was associated with M2 receptor overexpression. For the first time, biological abnormalities are identified in vagal syncope in which only clinical signs are, so far, taken into account for differential diagnosis and therapeutic management. Further work will be needed to validate potential biomarkers of risk or severity associated with the cholinergic system.

Indexed as

AcetylcholinesteraseAdultChildFemaleHumansMaleReceptors, MuscarinicRNA, MessengerSyncope, VasovagalAcetylcholinesteraseReceptors, MuscarinicRNA, Messenger

Identifiers

PMID31318899
PMCPMC6638918
OpenAlexW2963407010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.